VANI Financials

Income Statement
MetricQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025
Revenue
0
0
0
0
0
Cost of Revenue
0
0
0
0
0
Gross Profit
0
0
0
0
0
Operating Expenses
6.4M
-6.6%
6.8M
+0.1%
6.8M
+1.3%
6.7M
-5.9%
7.1M
R&D
4.5M
+1.5%
4.4M
-5.2%
4.6M
+2.5%
4.5M
-5.0%
4.8M
SG&A
2.4M
-0.4%
2.4M
+11.3%
2.2M
-1.2%
2.2M
-18.4%
2.7M
Operating Income
-6370000
+6.6%
-6817000
-0.1%
-6810000
-1.3%
-6725000
+5.9%
-7144000
EBITDA
-6242000
+6.7%
-6687000
+0.1%
-6695000
-1.1%
-6620000
+6.0%
-7042000
Net Income
-6370000
+6.0%
-6780000
-2.2%
-6633000
-1.6%
-6530000
+8.6%
-7144000
EPS (Basic)
$-0.07
+12.5%
$-0.08
+11.1%
$-0.09
+18.2%
$-0.11
+8.3%
$-0.12
EPS (Diluted)
$-0.07
+12.5%
$-0.08
+11.1%
$-0.09
+18.2%
$-0.11
+8.3%
$-0.12
Shares (Diluted)
87.1M
+7.2%
81.3M
+13.9%
71.4M
+19.5%
59.7M
+0.8%
59.2M
Vivani Medical, Inc. (DE) (VANI) โ€” Financials